Our Technology
Early in 2018, SCU received approval from the approval from the Australian Securities Exchange (ASX) regulator to venture into the cannabis cosmetic beauty product’s research and development. This allows SCU to carry out cannabis stem cell genetics, research and development of cannabis seed breeding as well as its medical applications of cannabinoid (CBD) and derivatives and other active compounds in cannabis plant.
In 2018, SCU has also successfully patented and completed the research and development of Dendrobium stem cell product in 2017 and started pilot production and marketing in Asia.
In 2016, SCU successfully commercialised the processing and production of pharmaceutical grade Resina Draconis medicine and has been a major supplier to China and Asia markets since.
SCU Patents
Entry barriers are high for stem cell bio-technology businesses because the inventors take many years or even an entire lifetime to conduct research and development of a successful product for commercial use.
SCU uses patents and trademarks to protect its investment in proprietary formulation technology.
SCU has applied for international patent protection (PCT/SG2014/000515) for its proprietary technology and method of isolating meristematic plant stem cells. It has also filed individual patent applications in China (201410486185.1) and Taiwan (104103026).
CORE PATENTS
Singapore
Patent Number - PCT/SG2014/000515
China
Patent Number - 201410486185.1
Taiwan
Patent Number - 104103026
About Stemcells
Stem cells are undifferentiated biological cells that have the remarkable potential to go through numerous cycles of cell division to produce more stem cells and develop into many different cell types. They are present in all living things including plants, animals, humans and algae. Stem cells are currently in the development of various therapies to treat human diseases and are also utilised as food ingredients, and in the production of beauty and skincare products, dietary supplements, and other healthcare products.
Scientists are anticipating early breakthroughs in the research of stem cells to provide alternatives to the current human reliance on drugs, devices and medical procedures. The science of stem cells therefore serves as a foundation to capitalise on business opportunities across multiple markets by applying it to the discovery, development and commercialisation of innovative therapies to treat a broad array of diseases and disorders.
Plant stem cells are innately undifferentiated cells found in the meristems of plants. A meristem is the tissue in most plants where growth takes place and the highest concentration of plant stem cells can be found at the root or shoot of the plant. Plant stem cells are totipotent, which means a small amount of meristem plant stem cells can proliferate and differentiate into full functioning independent ‘daughter’ plants with the correct inducements from environment stimulation or plant hormones.